- 专利标题： Oxymorphone controlled release formulations
-
申请号： US11680432申请日： 2007-02-28
-
公开(公告)号： US08309122B2公开(公告)日： 2012-11-13
- 发明人: Huai-Hung Kao , Anand R. Baichwal , Troy McCall , David Lee
- 申请人： Huai-Hung Kao , Anand R. Baichwal , Troy McCall , David Lee
- 申请人地址： US PA Chadds Ford
- 专利权人： Endo Pharmaceuticals Inc.
- 当前专利权人： Endo Pharmaceuticals Inc.
- 当前专利权人地址： US PA Chadds Ford
- 代理机构： Mayer Brown LLP
- 主分类号： A61K9/22
- IPC分类号： A61K9/22 ; A61K9/34 ; A61K9/36
摘要：
The invention pertains to a method of relieving pain by administering a controlled release pharmaceutical tablet containing oxymorphone which produces a mean minimum blood plasma level 12 to 24 hours after dosing, as well as the tablet producing the sustained pain relief.
公开/授权文献
- US20070134328A1 OXYMORPHONE CONTROLLED RELEASE FORMULATIONS 公开/授权日：2007-06-14
信息查询
